Do competing causes of mortality contribute to overdiagnosis in lung cancer screening?

Durham, Danielle D; Croswell, Jennifer M; Marcus, Pamela M

Durham, Danielle D; Croswell, Jennifer M; Marcus, Pamela M.

Afiliación

Durham DD; Department of Radiology, University of North Carolina, Chapel Hill, NC, United States; Cancer Prevention Fellowship Program, Division of Cancer Prevention, Healthcare Delivery Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute, Bethesda, MD, United States. Electronic address: danielle_durham@med.unc.edu.
Croswell JM; Healthcare Delivery Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute, Bethesda, MD, United States.
Marcus PM; Healthcare Delivery Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute, Bethesda, MD, United States.

Lung Cancer ; 153: 21-24, 2021 03.

Article en En | MEDLINE | ID: mdl-33445120

Asunto(s)

Detección Precoz del Cáncer; Neoplasias Pulmonares; Humanos; Neoplasias Pulmonares/diagnóstico; Neoplasias Pulmonares/epidemiología; Tamizaje Masivo; Uso Excesivo de los Servicios de Salud; Tomografía Computarizada por Rayos X

Palabras clave

Lung cancer screening; NLST; Overdiagnosis

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Detección Precoz del Cáncer / Neoplasias Pulmonares Tipo de estudio: Diagnostic_studies / Etiology_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Límite: Humans Idioma: En Revista: Lung Cancer Asunto de la revista: NEOPLASIAS Año: 2021 Tipo del documento: Article Pais de publicación: Irlanda

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google